FDA NEWSNews FDA Approves Emcitate (Tiratricol): First Treatment for MCT8 Deficiency (Allan-Herndon-Dudley Syndrome)
FDA NEWSNews FDA Approves Isembyld (Apitegromab-mstn), First Muscle-Targeted Therapy for Spinal Muscular Atrophy
FDA NEWSNews FDA Approves Qfitlia (Fitusiran) for Hemophilia A or B, with or without Factor Inhibitors
